• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNykode Therapeutics ASA
    Picture of Nykode Therapeutics ASA logo

    NYKD — Nykode Therapeutics ASA Share News

    NOK2.670.000.00%
    no flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapMomentum Trap
    • Market Cap
      NOK870.25m
    • Enterprise Value
      NOK450.97m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • Discussion
    • NYKD Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    Discussion
    NYKD Dividends
    • Brief: Nykode Therapeutics To Collaborate With GOG Foundation

      10/02/2023 06:16
    • Brief: Nykode Announces Expanded Clinical Development Plan For Its Lead Cancer Vaccine VB10.16

      20/12/2022 05:50
    • Brief: Nykode Therapeutics And Richter-Helm Biologics Announce Strategic Manufacturing Partnership

      19/12/2022 05:50
    • Brief: Nykode Therapeutics Enters Clinical Collaboration With MSD

      06/12/2022 15:49
    • Brief: Nykode Therapeutics Q3 Oper Loss Widens To $19.9 Million

      23/11/2022 06:06
    • Brief: Nykode Therapeutics Announces Positive Results From Phase 1/2 Open Label, Dose Escalation Trial Of SARS-CoV-2 Vaccine Candidate

      27/09/2022 05:48
    • Brief: Nykode Therapeutics Q2 Net Loss Widens To $8.7 Million

      24/08/2022 06:07
    • Brief: Vaccibody Enters Into Worldwide License Agreement With Adaptive Biotechnologies

      12/07/2021 05:48
    • Brief: Vaccibody: Promising Preclinical Data With COVID-19 Vaccine Candidate In Mice

      10/12/2020 08:54
    Previous123Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.